PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
1-Year Est. Return 13.3%
This Quarter Est. Return
1 Year Est. Return
+13.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$710M
AUM Growth
+$209M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
32
New
Increased
Reduced
Closed

Top Buys

1
+$41.3M
2
+$28.4M
3
+$23.2M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$21.7M
5
INCY icon
Incyte
INCY
+$14.5M

Top Sells

1
+$44.1M
2
+$18.4M
3
+$10.4M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$7.01M
5
UTHR icon
United Therapeutics
UTHR
+$4.71M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$80.1M 10.68%
1,175,879
-269,687
2
$59.4M 7.92%
850,385
+190,417
3
$51.5M 6.87%
773,082
+217,039
4
$51.4M 6.85%
497,347
+65,177
5
$43.9M 5.86%
1,076,591
+97,995
6
$41.3M 5.5%
+154,605
7
$36.3M 4.84%
773,079
+105,662
8
$33.6M 4.47%
1,636,211
+329,642
9
$31.9M 4.25%
90,297
+1,481
10
$29.4M 3.92%
140,561
-22,505
11
$28.4M 3.78%
+833,265
12
$27M 3.59%
1,158,686
+110,170
13
$26.1M 3.48%
1,085,142
+208,986
14
$23.2M 3.09%
+520,080
15
$21.7M 2.9%
+351,405
16
$15.9M 2.13%
2,214,722
+1,387,943
17
$14.3M 1.91%
+235,826
18
$12.6M 1.68%
283,777
-233,629
19
$11.5M 1.54%
1,719,831
+311,781
20
$11.3M 1.51%
564,214
+111,970
21
$11M 1.47%
+884,574
22
$10.2M 1.36%
+519,256
23
$9.26M 1.24%
1,648,316
+314,986
24
$8.91M 1.19%
1,505,479
-459,230
25
$7.31M 0.97%
+2,070,108
1
2